Clinical Trial Detail

NCT ID NCT04022785
Title PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

myeloproliferative neoplasm

Therapies

Azacitidine + PLX51107

Age Groups: adult senior

No variant requirements are available.